Remote Monitoring for Ileocolitis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Ileocolitis+6 More
Remote monitoring - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help assess whether or not a remote monitoring digital health system can improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease.

Eligible Conditions
  • Ileocolitis
  • Ulcerative Colitis
  • Inflammatory Bowel Diseases

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Ileocolitis

Study Objectives

2 Primary · 12 Secondary · Reporting Duration: 1 year

1 Year
Patient Reported Outcome (Anxiety)
1 year
Healthcare utilization
IBD Disease Activity
IBD Disease Activity (objective)
IBD Disease activity
IBD Disease activity (objective)
Medication adherence
Patient Reported Outcome (Depression)
Patient Reported Outcome (Fatigue)
Patient Reported Outcome (Pain interference)
Patient Reported Outcome (Sleep Disturbance)
Patient Reported Outcomes, Quality of Life
Self-efficacy
Self-reported medication adherence

Trial Safety

Safety Progress

1 of 3

Other trials for Ileocolitis

Trial Design

2 Treatment Groups

Control
1 of 2
Remote Monitoring
1 of 2
Active Control
Experimental Treatment

123 Total Participants · 2 Treatment Groups

Primary Treatment: Remote Monitoring · No Placebo Group · N/A

Remote Monitoring
Behavioral
Experimental Group · 1 Intervention: Remote monitoring · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Remote monitoring
2021
N/A
~420

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

New York UniversityOTHER
199 Previous Clinical Trials
300,818 Total Patients Enrolled
Synchronyx, LLCUNKNOWN
Vanderbilt University Medical CenterOTHER
768 Previous Clinical Trials
591,991 Total Patients Enrolled
University of CincinnatiOTHER
385 Previous Clinical Trials
630,375 Total Patients Enrolled
University of North Carolina, Chapel HillOTHER
1,359 Previous Clinical Trials
3,926,945 Total Patients Enrolled
University of Maryland, BaltimoreLead Sponsor
599 Previous Clinical Trials
332,592 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 18 years of age.\n
You have access to a mobile phone with reliable data and/or Wi-Fi access.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 13th, 2021

Last Reviewed: October 7th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.